US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 1.000
- +0.050+5.26%
Trading Nov 25 11:58 ET
279.22MMarket Cap-1265P/E (TTM)
1.040High0.950Low235.65KVolume0.960Open0.950Pre Close232.37KTurnover0.12%Turnover RatioLossP/E (Static)279.22MShares3.25652wk High0.53P/B203.60MFloat Cap0.85052wk Low--Dividend TTM203.60MShs Float19.840Historical High--Div YieldTTM9.47%Amplitude0.850Historical Low0.986Avg Price1Lot Size
Lyell Immunopharma Key Stats
EPS
According to the latest financial report of Lyell Immunopharma, the latest earnings per share (TTM) for the company is -0.17. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Lyell Immunopharma's free cash flow? The latest report shows it as -35.10M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lyell Immunopharma shows that the company's current ratio is 13.43, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lyell Immunopharma, the quick ratio is 13.15, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Lyell Immunopharma? The latest ROE figure is -8.13%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lyell Immunopharma, the total asset return on investment (ROA) is -7.00%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lyell Immunopharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lyell Immunopharma, the net profit margin is -131.13K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data